BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 29605372)

  • 1. Emberger syndrome: A rare association with hearing loss.
    Zawawi F; Sokolov M; Mawby T; Gordon KA; Papsin BC; Cushing SL
    Int J Pediatr Otorhinolaryngol; 2018 May; 108():82-84. PubMed ID: 29605372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First Korean case of Emberger syndrome (primary lymphedema with myelodysplasia) with a novel GATA2 gene mutation.
    Seo SK; Kim KY; Han SA; Yoon JS; Shin SY; Sohn SK; Moon JH
    Korean J Intern Med; 2016 Jan; 31(1):188-90. PubMed ID: 26767875
    [No Abstract]   [Full Text] [Related]  

  • 3. A Rare Case of Emberger Syndrome Caused By a De Novo Mutation in the GATA2 Gene.
    Michelini S; Cardone M; Haag M; Agga O; Bruson A; Maltese PE; Bonizzato A; Bertelli M
    Lymphology; 2016 Mar; 49(1):15-20. PubMed ID: 29906059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emberger syndrome-primary lymphedema with myelodysplasia: report of seven new cases.
    Mansour S; Connell F; Steward C; Ostergaard P; Brice G; Smithson S; Lunt P; Jeffery S; Dokal I; Vulliamy T; Gibson B; Hodgson S; Cottrell S; Kiely L; Tinworth L; Kalidas K; Mufti G; Cornish J; Keenan R; Mortimer P; Murday V;
    Am J Med Genet A; 2010 Sep; 152A(9):2287-96. PubMed ID: 20803646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GATA2 null mutation associated with incomplete penetrance in a family with Emberger syndrome.
    Brambila-Tapia AJL; García-Ortiz JE; Brouillard P; Nguyen HL; Vikkula M; Ríos-González BE; Sandoval-Muñiz RJ; Sandoval-Talamantes AK; Bobadilla-Morales L; Corona-Rivera JR; Arnaud-Lopez L
    Hematology; 2017 Sep; 22(8):467-471. PubMed ID: 28271814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GATA-2 anomaly and clinical phenotype of a sporadic case of lymphedema, dendritic cell, monocyte, B- and NK-cell (DCML) deficiency, and myelodysplasia.
    Ishida H; Imai K; Honma K; Tamura S; Imamura T; Ito M; Nonoyama S
    Eur J Pediatr; 2012 Aug; 171(8):1273-6. PubMed ID: 22430350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel germline GATA2 frameshift mutation with a premature stop codon in a family with congenital sensory hearing loss and myelodysplastic syndrome.
    Nakazawa H; Yamaguchi T; Sakai H; Maruyama M; Kawakami T; Kawakami F; Nishina S; Ishikawa M; Kosho T; Ishida F
    Int J Hematol; 2021 Aug; 114(2):286-291. PubMed ID: 33759087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity.
    Spinner MA; Sanchez LA; Hsu AP; Shaw PA; Zerbe CS; Calvo KR; Arthur DC; Gu W; Gould CM; Brewer CC; Cowen EW; Freeman AF; Olivier KN; Uzel G; Zelazny AM; Daub JR; Spalding CD; Claypool RJ; Giri NK; Alter BP; Mace EM; Orange JS; Cuellar-Rodriguez J; Hickstein DD; Holland SM
    Blood; 2014 Feb; 123(6):809-21. PubMed ID: 24227816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Facial lymphoedema, viral warts, and myelodysplastic syndrome: the protean condition of GATA2 deficiency.
    Rudd EC; Kulasekararaj A; Basu TN
    Lancet; 2022 Jul; 400(10347):236. PubMed ID: 35843247
    [No Abstract]   [Full Text] [Related]  

  • 10. Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome).
    Ostergaard P; Simpson MA; Connell FC; Steward CG; Brice G; Woollard WJ; Dafou D; Kilo T; Smithson S; Lunt P; Murday VA; Hodgson S; Keenan R; Pilz DT; Martinez-Corral I; Makinen T; Mortimer PS; Jeffery S; Trembath RC; Mansour S
    Nat Genet; 2011 Sep; 43(10):929-31. PubMed ID: 21892158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GATA2 is required for lymphatic vessel valve development and maintenance.
    Kazenwadel J; Betterman KL; Chong CE; Stokes PH; Lee YK; Secker GA; Agalarov Y; Demir CS; Lawrence DM; Sutton DL; Tabruyn SP; Miura N; Salminen M; Petrova TV; Matthews JM; Hahn CN; Scott HS; Harvey NL
    J Clin Invest; 2015 Aug; 125(8):2979-94. PubMed ID: 26214525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin manifestations among GATA2-deficient patients.
    Polat A; Dinulescu M; Fraitag S; Nimubona S; Toutain F; Jouneau S; Poullot E; Droitcourt C; Dupuy A
    Br J Dermatol; 2018 Mar; 178(3):781-785. PubMed ID: 28440875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evolution of cellular deficiency in GATA2 mutation.
    Dickinson RE; Milne P; Jardine L; Zandi S; Swierczek SI; McGovern N; Cookson S; Ferozepurwalla Z; Langridge A; Pagan S; Gennery A; Heiskanen-Kosma T; Hämäläinen S; Seppänen M; Helbert M; Tholouli E; Gambineri E; Reykdal S; Gottfreðsson M; Thaventhiran JE; Morris E; Hirschfield G; Richter AG; Jolles S; Bacon CM; Hambleton S; Haniffa M; Bryceson Y; Allen C; Prchal JT; Dick JE; Bigley V; Collin M
    Blood; 2014 Feb; 123(6):863-74. PubMed ID: 24345756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GATA2 Deficiency in a Pediatric Patient.
    Mojica AM; Elizalde A
    J Allergy Clin Immunol Pract; 2019; 7(6):2021-2022. PubMed ID: 30894283
    [No Abstract]   [Full Text] [Related]  

  • 15. GATA2 Deficiency Due to de Novo Complete Monoallelic Deletion in an Adolescent With Myelodysplasia.
    Vinh DC; Palma L; Storring J; Foulkes WD
    J Pediatr Hematol Oncol; 2018 May; 40(4):e225-e228. PubMed ID: 29620682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic Screening in a Large Cohort of Italian Patients Affected by Primary Lymphedema Using a Next Generation Sequencing (NGS) Approach.
    Michelini S; Vettori A; Maltese PE; Cardone M; Bruson A; Fiorentino A; Cappellino F; Sainato V; Guerri G; Marceddu G; Tezzele S; Bertelli M
    Lymphology; 2016 Jun; 49(2):57-72. PubMed ID: 29906362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GATA2 mutations lead to MDS and AML.
    Hyde RK; Liu PP
    Nat Genet; 2011 Sep; 43(10):926-7. PubMed ID: 21956389
    [No Abstract]   [Full Text] [Related]  

  • 18. Loss of B cells and their precursors is the most constant feature of GATA-2 deficiency in childhood myelodysplastic syndrome.
    Nováková M; Žaliová M; Suková M; Wlodarski M; Janda A; Froňková E; Campr V; Lejhancová K; Zapletal O; Pospíšilová D; Černá Z; Kuhn T; Švec P; Pelková V; Zemanová Z; Kerndrup G; van den Heuvel-Eibrink M; van der Velden V; Niemeyer C; Kalina T; Trka J; Starý J; Hrušák O; Mejstříková E
    Haematologica; 2016 Jun; 101(6):707-16. PubMed ID: 27013649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Application of next generation sequencing in congenital sensorineural deafness].
    Xu B; Chen Y; Jiang A; Chen C; Wang K; Zheng J; Fu Y
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Jun; 32(11):811-815. PubMed ID: 29921047
    [No Abstract]   [Full Text] [Related]  

  • 20. Performance evaluation of the next-generation sequencing approach for molecular diagnosis of hereditary hearing loss.
    Sivakumaran TA; Husami A; Kissell D; Zhang W; Keddache M; Black AP; Tinkle BT; Greinwald JH; Zhang K
    Otolaryngol Head Neck Surg; 2013 Jun; 148(6):1007-16. PubMed ID: 23525850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.